Houlihan Lokey Advises Intouch Group

Houlihan Lokey is pleased to announce that Intouch Group®, a full-service global agency network serving the pharmaceutical industry, has completed its acquisition by EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry. The transaction closed on December 16, 2021.

Intouch Group is a privately held full-service agency network, providing creative and media services, enterprise solutions and data analytics globally through ten affiliates in eight offices, including Intouch Solutions, Intouch Proto, Intouch Seven, Intouch Oxygen, Intouch International, Intouch Media, Intouch B2D, Intouch Analytics, Intouch Market Access, and Intouch MedComm. Collectively, Intouch Group employs more than 1,400 people. With a dedication to the life sciences, Intouch Group operates with the belief that there is no challenge too big to cure.

EVERSANA™ is the leading provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product lifecycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organizations, including innovative startups and established pharmaceutical companies, to advance life sciences solutions for a healthier world.

Under terms of the agreement announced in October 2021, Intouch’s industry-leading creative and media services, enterprise solutions and data analytics will join EVERSANA’s fully integrated commercialization services platform.

Houlihan Lokey served as the exclusive financial advisor to Intouch Group and assisted in structuring and negotiating the transaction on its behalf. This deal highlights Houlihan Lokey’s leading experience in the pharma services space and represents the firm’s 12th transaction in this sector since 2019.

RELATED: Business Services, Pharma Commercialization